Fred Alger Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,583
| Closed | -$364K | – | 475 |
|
|
2025
Q4 | $364K | Sell |
3,583
-559,709
| -99% | -$44.9M | ﹤0.01% | 410 |
|
|
2025
Q3 | $30.8M | Buy |
+563,292
| New | +$28.1M | 0.12% | 91 |
|
|
2024
Q4 | – | Sell |
-30,536
| Closed | -$2.08M | – | 432 |
|
|
2024
Q3 | $2.08M | Buy |
+30,536
| New | +$1.72M | 0.01% | 323 |
|
|
2024
Q2 | – | Sell |
-8,654
| Closed | -$598K | – | 443 |
|
|
2024
Q1 | $598K | Sell |
8,654
-95,628
| -92% | -$6.05M | ﹤0.01% | 389 |
|
|
2023
Q4 | $7.71M | Buy |
104,282
+47,263
| +83% | +$3.1M | 0.04% | 204 |
|
|
2023
Q3 | $3.89M | Sell |
57,019
-53,405
| -48% | -$4.53M | 0.02% | 269 |
|
|
2023
Q2 | $10.4M | Buy |
110,424
+80,848
| +273% | +$6.31M | 0.05% | 192 |
|
|
2023
Q1 | $2.01M | Buy |
+29,576
| New | +$1.9M | 0.01% | 347 |
|
|
2021
Q3 | – | Sell |
-30,616
| Closed | -$3.81M | – | 530 |
|
|
2021
Q2 | $3.81M | Sell |
30,616
-162,480
| -84% | -$19.4M | 0.01% | 319 |
|
|
2021
Q1 | $25.4M | Sell |
193,096
-6,155
| -3% | -$843K | 0.07% | 194 |
|
|
2020
Q4 | $26.4M | Buy |
199,251
+125,083
| +169% | +$15.1M | 0.07% | 181 |
|
|
2020
Q3 | $7.56M | Buy |
74,168
+16,116
| +28% | +$1.39M | 0.02% | 218 |
|
|
2020
Q2 | $5.05M | Buy |
58,052
+5,833
| +11% | +$466K | 0.02% | 229 |
|
|
2020
Q1 | $3.03M | Sell |
52,219
-7,835
| -13% | -$636K | 0.01% | 247 |
|
|
2019
Q4 | $5.55M | Sell |
60,054
-624,641
| -91% | -$54.9M | 0.02% | 224 |
|
|
2019
Q3 | $61.9M | Sell |
684,695
-9,434
| -1% | -$1.07M | 0.24% | 102 |
|
|
2019
Q2 | $81.9M | Sell |
694,129
-4,975
| -0.7% | -$501K | 0.31% | 84 |
|
|
2019
Q1 | $60.6M | Sell |
699,104
-60,710
| -8% | -$5.17M | 0.24% | 94 |
|
|
2018
Q4 | $47.9M | Sell |
759,814
-80,011
| -10% | -$5.49M | 0.22% | 100 |
|
|
2018
Q3 | $66.3M | Sell |
839,825
-510,821
| -38% | -$33.3M | 0.25% | 90 |
|
|
2018
Q2 | $80.8M | Sell |
1,350,646
-1,494,242
| -53% | -$80.4M | 0.34% | 59 |
|
|
2018
Q1 | $115M | Buy |
2,844,888
+1,076,357
| +61% | +$52.5M | 0.53% | 43 |
|
|
2017
Q4 | $92.9M | Sell |
1,768,531
-291,871
| -14% | -$15.6M | 0.42% | 58 |
|
|
2017
Q3 | $97.1M | Sell |
2,060,402
-319,508
| -13% | -$12.9M | 0.45% | 54 |
|
|
2017
Q2 | $84.2M | Buy |
+2,379,910
| New | +$73.5M | 0.4% | 65 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Fred Alger Management's EXAS Position: Q1 2026 in Review
Fred Alger Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,583 shares — an estimated $364K sold.
Fred Alger Management first reported a position in EXAS in Q2 2017 and held it in 25 quarters. The position peaked at $115M in Q1 2018. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Fred Alger Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Fred Alger Management sold 3,583 Exact Sciences shares in Q1 2026, an estimated $364K.
- Fred Alger Management first reported a position in Exact Sciences in Q2 2017 and held it in 25 quarters.
- Fred Alger Management's Exact Sciences position peaked at $115M in Q1 2018.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.